title: Antiretroviral therapy recommendations for the global community: aspiration versus reality.
authors.affiliation: aResearch Department of Infection & Population Health, University College London, London, UK bMRC/UVRI Uganda Research Unit on AIDS, Uganda cUniversity of York, York, UK dIndustrial and Commercial Abatement Program, Colombia University, New York, New York, USA eCHIP @ Department of Infectious Diseases (8632), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Phillips
authors.forename: Paula
authors.initials: P
authors.lastname: Munderi
authors.forename: Paul A
authors.initials: PA
authors.lastname: Revill
authors.forename: Wafaa M
authors.initials: WM
authors.lastname: El-Sadr
authors.forename: Jens D
authors.initials: JD
authors.lastname: Lundgren
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D003362:Cost-Benefit Analysis; D014943:Global Health; D017408:Guidelines as Topic; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D008962:Models, Theoretical; D013997:Time Factors
chemical_list: D044966:Anti-Retroviral Agents